Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 43
Filtrar
1.
Chirurg ; 89(1): 32-39, 2018 01.
Artigo em Alemão | MEDLINE | ID: mdl-29197019

RESUMO

Quality indicators are by definition indirect measures of quality. The selection for the field of pancreatic surgery was based on the clinical relevance and controllability, scientific evidence and the practicability of data acquisition. In terms of outcome quality, hospital mortality, the composite endpoint MTL30 (mortality-transfer-length of stay), and major complications (Clavien-Dindo classification grades 3b and 4) were chosen as being essential. With respect to structural quality, the presence of interventional radiology with constant availability was considered essential. To evaluate target values two strategies were used: a systematic literature search and evaluation of the current numbers from the German Society for General and Visceral Surgery (DGAV) StuDoQ|Pancreas registry for the years 2014-2016. The results are presented in the following consensus statement.


Assuntos
Pâncreas , Neoplasias Pancreáticas , Indicadores de Qualidade em Assistência à Saúde , Consenso , Mortalidade Hospitalar , Humanos , Pâncreas/cirurgia , Neoplasias Pancreáticas/cirurgia , Sistema de Registros
2.
Zentralbl Chir ; 136(1): 56-60, 2011 Feb.
Artigo em Alemão | MEDLINE | ID: mdl-21337292

RESUMO

BACKGROUND: The therapy for open abdomen remains challenging. Abdominal vacuum therapy seems to simplify the treatment and to enable a direct fascial closure in a high percentage of the patients. PATIENTS AND METHODS: A retrospective analysis of 82 consecutive patients who underwent abdominal vacuum therapy between January 2005 and December 2007 was undertaken. Indications, -duration of treatment, complications as well as rate and type of abdominal wall closure were evaluated. RESULTS: The 82 consecutive patients consisted of 46 % female and 54 % male patients with a median age of 65.5 years. The most frequent diagnoses were colorectal carcinoma (24 %, n = 28, colon n = 18 and rectum n = 10), inflammatory bowel dis-ease (13 %), perforated peptic ulcer (9 %), necrotising pancreatitis (7 %), peritoneal carcinosis (5 %), ileus (5 %) and mesenteric ischaemia (4 %). The predominant indication for vacuum therapy was peritonitis (88 %). Vacuum therapy treatment was applied for a median of 6 days (range: 1-73 days). 18 patients (22 %) received intraabdominal foam dressings without the fenestrated polyurethane layer. In 70 % of all cases the abdominal vacuum therapy was performed without complications. 16 patients (19.5 %) developed intestinal fistulas. However, fistulas were not observed among the patients who were treated with foam dressings without a polyurethane layer. Abdominal bleeding was observed in 8 patients (10 %) and a persistent abdominal compartment syndrome was seen in one patient. Nine patients (11 %) died during hospitalisation. After completion of the intraabdominal vacuum therapy, -direct fascial closure was feasible in 35 patients (43 %). In 47 patients (57 %) an absorbable synthetic mesh was required for fascial closure. Symptomatic incisional hernias -occurred in 22 % of the patients. CONCLUSION: Abdominal vacuum therapy simplifies the treatment of patients with abdominal catastrophes such as peritonitis or necrotising pancreatitis. The cost-effective intraperitoneal use of a foam dressing without a fenestrated polyurethane layer was possible without an increased rate of fistulas. This retrospective analysis demonstrates that abdominal vacuum therapy can be performed without complications in the majority of patients. Furthermore, direct fascial closure is possible in almost half of the patients.


Assuntos
Parede Abdominal/cirurgia , Gastroenteropatias/cirurgia , Neoplasias Gastrointestinais/cirurgia , Tratamento de Ferimentos com Pressão Negativa/métodos , Peritonite/cirurgia , Complicações Pós-Operatórias/cirurgia , Cicatrização/fisiologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Neoplasias Colorretais/cirurgia , Fasciotomia , Feminino , Hérnia Abdominal/cirurgia , Humanos , Doenças Inflamatórias Intestinais/cirurgia , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Telas Cirúrgicas
3.
Dig Dis ; 28(6): 792-8, 2010.
Artigo em Inglês | MEDLINE | ID: mdl-21525764

RESUMO

BACKGROUND/AIMS: Alcoholic liver disease is continuously increasing in developed countries being a leading cause of death worldwide. Chronic ethanol consumption induces oxidative stress by accumulation of reactive oxygen intermediates (ROI) while reducing the cellular antioxidant defense. Induction of heme oxygenase-1 (HO-1) may protect primary human hepatocytes (hHeps) from such damage. Thus, the aim of this study was to investigate the potential of polyphenols to protect hHeps from ethanol-dependent oxidative damage. METHODS: hHeps were isolated by collagenase perfusion. ROI and cellular glutathione (GSH) were measured by fluorescent-based assays. Cellular damage was determined by lactate dehydrogenase (LDH) leakage and staining for apoptosis and necrosis. Nuclear translocation of Nrf2 and HO-1 expression were analyzed by Western blot. RESULTS: Ethanol and TGF-ß rapidly increase ROI and reduce GSH in hHeps, causing apoptosis with a release of approximately 40% total LDH after 72 h. Similar to incubation with hemin preincubation and co-incubation of cells with nifedipine, verapamil and quercetin significantly reduce oxidative stress and resulting cellular damage, in a dose-dependent manner, by initiating nuclear translocation of Nrf2 which in turn induces HO-1 under the control of p38 and ERK. Blocking of HO-1 activity with ZNPP9 reverses the protective effect of all three substances. CONCLUSION: Our results suggest that increasing HO-1 activity in hHeps protects them from oxidative stress-dependent damage. As polyphenols have great potential to induce HO-1 expression, they may play an important role for future therapeutic strategies to protect liver from oxidative stress-dependent damage observed during chronic alcohol consumption.


Assuntos
Heme Oxigenase-1/metabolismo , Hepatopatias Alcoólicas/enzimologia , Hepatopatias Alcoólicas/prevenção & controle , Substâncias Protetoras/metabolismo , Soluções Tampão , Citoproteção/efeitos dos fármacos , Etanol/toxicidade , Flavonoides/farmacologia , Hepatócitos/efeitos dos fármacos , Hepatócitos/enzimologia , Hepatócitos/metabolismo , Hepatócitos/patologia , Humanos , L-Lactato Desidrogenase/metabolismo , Hepatopatias Alcoólicas/patologia , Modelos Biológicos , Estresse Oxidativo/efeitos dos fármacos , Fenóis/farmacologia , Polifenóis , Fator de Crescimento Transformador beta/toxicidade , Regulação para Cima/efeitos dos fármacos
4.
Zentralbl Chir ; 134(2): 182-5, 2009 Apr.
Artigo em Alemão | MEDLINE | ID: mdl-19382053

RESUMO

Intraductal papillary mucinous neoplasms (IPMNs) of the pancreas are intraductally located, mucin-producing cystic neoplasms of the pancreas with a malignant potential. We report about a 54-year-old female who underwent segmental resection of the pancreas for non-invasive IPMN. The surgical margins were tumour-negative. Three years later a highly suspicious tumour of the pancreatic tail was detected during routine follow-up. Resection of the pancreatic tail was performed. The histological analysis revealed an adenocarcinoma. This case suggests the development of a pancreatic carcinoma from a non-invasive IPMN and raises the question about the extent of surgery of non-invasive IPMNs of the pancreas.


Assuntos
Adenocarcinoma/cirurgia , Carcinoma Ductal Pancreático/cirurgia , Cistadenoma Mucinoso/cirurgia , Cistadenoma Papilar/cirurgia , Neoplasias Primárias Múltiplas/cirurgia , Adenocarcinoma/diagnóstico por imagem , Adenocarcinoma/patologia , Carcinoma Ductal Pancreático/classificação , Carcinoma Ductal Pancreático/diagnóstico por imagem , Carcinoma Ductal Pancreático/patologia , Cistadenoma Mucinoso/classificação , Cistadenoma Mucinoso/diagnóstico por imagem , Cistadenoma Mucinoso/patologia , Cistadenoma Papilar/classificação , Cistadenoma Papilar/diagnóstico por imagem , Cistadenoma Papilar/patologia , Feminino , Humanos , Pessoa de Meia-Idade , Neoplasias Primárias Múltiplas/diagnóstico por imagem , Neoplasias Primárias Múltiplas/patologia , Pâncreas/patologia , Pancreatectomia , Radiografia , Reoperação
6.
Eur Surg Res ; 41(3): 253-9, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-18577870

RESUMO

BACKGROUND: As a basis for future clinical questions, we evaluated the efficacy of hepatocyte transplantation in a surgical model using a subperitoneal or intrasplenic approach for cell implantation. METHODS: In rats, acute liver failure was induced by subtotal hepatectomy. Series of allogenic hepatocyte transplantations were performed by varying cell number, site, and sequence of cell transplantation. RESULTS: Following subperitoneal or intrasplenic cell implantation subsequent to liver surgery, no survival benefit was achieved when compared to the control groups. However, intrasplenic cell implantation 24 h prior to liver surgery revealed a statistically significantly higher animal survival (72 vs. 29%). CONCLUSION: According to our experience, both timing and site of cell implantation played an important role in hepatocyte transplantation. Intrasplenic hepatocyte transplantation 1 day before liver surgery showed the best results in terms of survival. Consequently, we were able to establish a model of hepatocyte transplantation which may be the basis for further investigations evaluating potential treatment modalities to overcome deleterious postoperative liver insufficiency.


Assuntos
Hepatócitos/transplante , Falência Hepática Aguda/cirurgia , Transplante de Fígado/métodos , Animais , Contagem de Células , Hepatectomia , Hepatócitos/citologia , Injeções , Injeções Intraperitoneais , Falência Hepática Aguda/etiologia , Falência Hepática Aguda/patologia , Transplante de Fígado/patologia , Masculino , Ratos , Ratos Wistar , Baço/patologia , Baço/cirurgia , Fatores de Tempo
7.
Clin Pharmacol Ther ; 82(3): 265-74, 2007 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-17344806

RESUMO

The pyrazolone drug metamizole is a widely used analgesic. Analysis of liver microsomes from patients treated with metamizole revealed selectively higher expression of cytochromes P450, CYP2B6 and CYP3A4 (3.8- and 2.8-fold, respectively), and 2.9-fold higher bupropion hydroxylase activity compared with untreated subjects. Further investigation of metamizole and various derivatives on different potential target genes in human primary hepatocytes demonstrated time- and concentration-dependent induction by metamizole of CYP2B6 (7.8- and 3.1-fold for mRNA and protein, respectively, at 100 muM) and CYP3A4 (2.4- and 2.9-fold, respectively), whereas other genes (CYP2C9, CYP2C19, CYP2D6, NADPH:cytochrome P450 reductase, ABCB1, constitutive androstane receptor (CAR), pregnane X receptor (PXR)) were not substantially altered. Using reporter gene assays, we show that metamizole is not acting as a direct ligand to either PXR or CAR, suggesting a phenobarbital-like mechanism of induction. These data warrant further studies to elucidate the drug-interaction potential of metamizole, especially in patients with long-term treatment.


Assuntos
Anti-Inflamatórios não Esteroides/farmacologia , Hidrocarboneto de Aril Hidroxilases/biossíntese , Sistema Enzimático do Citocromo P-450/biossíntese , Dipirona/farmacologia , Oxirredutases N-Desmetilantes/biossíntese , Idoso , Hidrocarboneto de Aril Hidroxilases/genética , Western Blotting , Catálise , Células Cultivadas , Receptor Constitutivo de Androstano , Citocromo P-450 CYP2B6 , Citocromo P-450 CYP3A , Sistema Enzimático do Citocromo P-450/genética , DNA/biossíntese , DNA/genética , Dipirona/análogos & derivados , Relação Dose-Resposta a Droga , Indução Enzimática/efeitos dos fármacos , Feminino , Genótipo , Hepatócitos/efeitos dos fármacos , Humanos , Técnicas In Vitro , Isoenzimas/metabolismo , Fígado/efeitos dos fármacos , Fígado/enzimologia , Masculino , Microssomos Hepáticos/efeitos dos fármacos , Microssomos Hepáticos/enzimologia , Pessoa de Meia-Idade , Oxirredutases N-Desmetilantes/genética , Plasmídeos , Receptor de Pregnano X , RNA/biossíntese , RNA/genética , Receptores Citoplasmáticos e Nucleares/efeitos dos fármacos , Receptores de Esteroides/efeitos dos fármacos , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Fatores de Transcrição/efeitos dos fármacos
8.
Transplant Proc ; 37(2): 1074-5, 2005 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-15848626

RESUMO

INTRODUCTION: To obtain better insight into the kinetics of hepatic growth factors following partial hepatectomy for living related liver donation, we investigated the postoperative changes in serum levels of hepatocyte growth factor (HGF), epidermal growth factor (EGF), vascular epidermal growth factor (VEGF), and transforming growth factor-alpha (TGF-alpha). PATIENTS AND METHODS: Eighteen healthy donors undergoing right hepatectomy for living related donation were enrolled in this study. Serum levels of HGF, EGF, VEGF, and TGF-alpha were measured using enzyme-linked immunosorbent assay kits before surgery, at 2 hours after resection, and daily during 5 days postoperatively. RESULTS: Mean preoperative HGF serum levels in healthy adults were 778 +/- 64 pg/mL. Within 2 hours after operation, they significantly increased to 9608 +/- 3111 pg/mL afterward decreasing to 2726 +/- 241 at day 1 and 2283 +/- 250 pg/mL at day 2. Hereafter HGF serum levels stabilized at increased levels until day 5 (2109 +/- 138, 2047 +/- 219, 2283 +/- 336 pg/mL, respectively). At all time points, the differences between pre- and postoperative HGF levels were significant (P < .01). In contrast, VEGF and EGF serum levels showed no significant differences between pre- and postoperative levels at all time points. TGF-alpha was not detected using a commercially available test with a detection limit of 10 ng/mL, suggesting only low TGF-alpha serum levels following liver resection. CONCLUSION: Significantly increased HGF serum levels after hepatectomy demonstrate its crucial role among the other investigated growth factors in regeneration of the remnant liver tissue during the early period after the operation.


Assuntos
Substâncias de Crescimento/sangue , Hepatectomia , Fígado , Doadores Vivos , Coleta de Tecidos e Órgãos , Fator de Crescimento Epidérmico/sangue , Fator de Crescimento de Hepatócito/sangue , Humanos , Período Pós-Operatório , Valores de Referência , Fator de Crescimento Transformador alfa/sangue , Fator A de Crescimento do Endotélio Vascular/sangue
9.
Dtsch Med Wochenschr ; 130(8): 387-92, 2005 Feb 25.
Artigo em Alemão | MEDLINE | ID: mdl-15717248

RESUMO

BACKGROUND AND OBJECTIVE: Intestinal transplantation (ITx) is the only causal therapy of short bowel syndrome (SBS). Long-term survival after ITx has been improved significantly during the last years. The experience with ITx at the Charite, Campus Virchow Klinikum, are described and discussed. PATIENTS AND METHODS: Twelve isolated ITx and one multivisceral transplantation (including stomach, pancreatodudenal complex, small intestine, liver, ascending colon, right kidney, and adrenal gland) were performed. Mean recipient age was 37.7+/-10.6 yrs (median: 35 yrs; range: 27 - 58 yrs; M:F = 8:5). All patients had irreversible SBS (0 - 30 cm residual bowel length; mean: 11.8+/-11.4 cm; median: 13 cm). RESULTS: 6-months and 1-year patient and graft survival were 85 % (11/13) and 77 % (10/13), respectively. Reasons for graft loss and patient death were necrotizing enterocolitis, severe, muromonab-resistent, acute rejection, and graft ischemia due to complex coagulopathy. All other patients had good long-term outcome. They received enteral nutrition at six hours after operation and were persistently off total parenteral nutrition (TPN) by week two after ITx. CONCLUSION: ITx as established in our centre, with 1-year-patient and graft survival rates of 77 %, reflects current international standard. ITx is complementary to conservative and other operative methods of treating SBS. Referral and indication criteria need wider dissemination to prevent life-threatening complications of TPN.


Assuntos
Intestinos/transplante , Síndrome do Intestino Curto/cirurgia , Adolescente , Glândulas Suprarrenais/transplante , Adulto , Berlim , Criança , Nutrição Enteral , Enterocolite Necrosante/complicações , Feminino , Seguimentos , Rejeição de Enxerto , Sobrevivência de Enxerto , Humanos , Imunossupressores/uso terapêutico , Intestino Delgado/transplante , Transplante de Rim , Transplante de Fígado , Masculino , Pessoa de Meia-Idade , Transplante de Pâncreas , Nutrição Parenteral Total/efeitos adversos , Complicações Pós-Operatórias/epidemiologia , Complicações Pós-Operatórias/prevenção & controle , Síndrome do Intestino Curto/terapia , Estômago/transplante , Taxa de Sobrevida , Fatores de Tempo , Doadores de Tecidos/estatística & dados numéricos
15.
Chirurg ; 73(1): 86-9, 2002 Jan.
Artigo em Alemão | MEDLINE | ID: mdl-11974468

RESUMO

Mesenteric artery occlusions are rare complications of Thrombangiitis obliterans (Buerger's disease). We report on a 30-year old male with Thrombangiitis obliterans and mesenteric occlusion as a complication of this disease. Because of unclear abdominal pain, laparoscopy was performed which showed small bowel infarction and reduced liver perfusion. After small bowel resection and a second examination, ischemia of the intestinum continued. Angiography was performed, which showed central occlusion of the celiac trunk and the superior mesenteric artery. Relaparotomy with the embolectomy of the superior mesenteric artery, venous bypass from the sup.mes.art. to the hepatic arteries and repeated small bowel resection was performed. The patient recovered completely and was discharged from hospital after 3 weeks. After a further admission to the hospital 3 weeks later with abdominal pain caused by acute occlusion of the right colonic artery and severe ischemia of the right hemicolon, a right hemicolectomy was performed. Now, one year after the last hospital admission, the patient shows no sign of having any abdominal problems.


Assuntos
Oclusão Vascular Mesentérica/etiologia , Tromboangiite Obliterante/complicações , Adulto , Angiografia , Arteriopatias Oclusivas/diagnóstico , Prótese Vascular , Artéria Celíaca , Colectomia , Colo/irrigação sanguínea , Embolectomia , Seguimentos , Artéria Hepática/cirurgia , Humanos , Intestino Delgado/irrigação sanguínea , Laparotomia , Masculino , Artérias Mesentéricas/cirurgia , Oclusão Vascular Mesentérica/diagnóstico , Oclusão Vascular Mesentérica/diagnóstico por imagem , Oclusão Vascular Mesentérica/cirurgia , Reoperação , Tromboangiite Obliterante/diagnóstico , Tromboangiite Obliterante/diagnóstico por imagem , Fatores de Tempo
16.
Langenbecks Arch Surg ; 386(4): 257-60, 2001 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-11466566

RESUMO

Abstract. We performed 343 vascular reconstructions of the supraaortal arteries from April 1996 to April 2000. Of these patients, 30 underwent combined vascular reconstructions - 22 combined extrathoracal and 8 combined transthoracal reconstructions. In 15 patients, carotid endarterectomy was combined with other cervical surgical interventions. In 10 patients, the vascular operation was combined with surgical interventions in other regions. No permanent complications were observed 8-52 months postoperatively, with the exception of one hemiparesis in the complex vascular operations. Consequently, we recommend the simultaneous surgical approach after careful individual assessment.


Assuntos
Doenças das Artérias Carótidas/cirurgia , Procedimentos Cirúrgicos Operatórios , Adulto , Idoso , Idoso de 80 Anos ou mais , Doenças das Artérias Carótidas/mortalidade , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Procedimentos Cirúrgicos Operatórios/mortalidade , Resultado do Tratamento , Procedimentos Cirúrgicos Vasculares/mortalidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...